Skip to main content
Top
Gepubliceerd in: Journal of Behavioral Medicine 3/2021

20-02-2021

The relationship between sleep and opioids in chronic pain patients

Auteurs: Amy Frers, Jonathan Shaffer, Jack Edinger, Amy Wachholtz

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 3/2021

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Background. Sleep problems are common among chronic pain patients who take opioids. There are documented effects of opioids on sleep architecture; however, the long-term effects of opioids on sleep remain unknown. This study examined whether opioid-naïve participants have better sleep quality than current and previous chronic users of opioids. We also explored whether sleep differed between methadone and buprenorphine users, and whether amount of time since abstaining from opioids was associated with sleep quality. Method. Participants were 120 people with chronic pain (84.2% Caucasian, Mage = 42.0 years, SD = 11.44). They were in one of four groups of 30 participants each: (1) current users of methadone for opioid use disorder (OUD); (2) current users of buprenorphine for OUD; (3) a history of medication-assisted therapy for OUD but currently opioid-abstinent for at least 6 months; (4) those who have less than one month of cumulative lifetime opioids (opioid-naïve group). Only participants in group 1 and group 2 were taking opioids during the time of the study. Participants completed the Pittsburgh Sleep Quality Index and the SF-36. Results. A MANCOVA revealed that all three groups with current or previous opioid use (i.e., groups 1–3) differed significantly from the opioid-naïve group (group 4) on sleep quality, sleep duration, sleep disturbances, and daytime dysfunction after controlling for sleep medications (all p < .05). For group 1 (methadone users), 2 (buprenorphine users), and 3 (prolonged abstinence), there were no statistically significant differences between each group. There was also a significant relationship between opioid-abstinent weeks and sleep disturbances in the opioid-abstinent group (r = − 0.604, p < .001). Discussion. The results of this study suggest that opioids interfere with sleep quality, even after months of abstention. Further research into the long-term effects of opioids is warranted and may contribute further to the importance of addressing sleep problems in this population.
Literatuur
go back to reference Benyamin, R., Trescot, A., Sukdeb, D., Buenaventura, R., Adlaka, R., Sehgal, N., & Vallejo, R. (2008). Opioid complications and side effects. Pain physician, 11, S105–S120. CrossRef Benyamin, R., Trescot, A., Sukdeb, D., Buenaventura, R., Adlaka, R., Sehgal, N., & Vallejo, R. (2008). Opioid complications and side effects. Pain physician, 11, S105–S120. CrossRef
go back to reference Drum. . (1999). The chronic pain management sourcebook. Los Angeles: Lowell House. Drum. . (1999). The chronic pain management sourcebook. Los Angeles: Lowell House.
go back to reference GauthierElizabeth, A. B. S., GuzickSarah, E. B. S., BrummettChad, M. M. D., BaghdoyanHelen, A. P. D., & Lydic, R. P. D. (2011). Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep regulating brain regions of sprague dawley rat. Anesthesiology: The Journal of the American Society of Anesthesiologists, 115, 743–753. CrossRef GauthierElizabeth, A. B. S., GuzickSarah, E. B. S., BrummettChad, M. M. D., BaghdoyanHelen, A. P. D., & Lydic, R. P. D. (2011). Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep regulating brain regions of sprague dawley rat. Anesthesiology: The Journal of the American Society of Anesthesiologists, 115, 743–753. CrossRef
go back to reference Nelson, A. M. B. A., Battersby, A. S. B. S., Baghdoyan, H. A. P. D., & Lydic, R. P. D. (2009). Opioid-induced decreases in rat brain adenosine levels are reversed by inhibiting adenosine deaminase. Anesthesiology: The Journal of the American Society of Anesthesiologists, 111, 1327–1333. CrossRef Nelson, A. M. B. A., Battersby, A. S. B. S., Baghdoyan, H. A. P. D., & Lydic, R. P. D. (2009). Opioid-induced decreases in rat brain adenosine levels are reversed by inhibiting adenosine deaminase. Anesthesiology: The Journal of the American Society of Anesthesiologists, 111, 1327–1333. CrossRef
go back to reference Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: A clinical practice guideline from the american college of physicians management of chronic insomnia disorder in adults. Annals of Internal Medicine, 165(2), 125–133. https://​doi.​org/​10.​7326/​M15-2175. CrossRefPubMed Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: A clinical practice guideline from the american college of physicians management of chronic insomnia disorder in adults. Annals of Internal Medicine, 165(2), 125–133. https://​doi.​org/​10.​7326/​M15-2175. CrossRefPubMed
go back to reference Walker, J. M., Farney, R. J., Rhondeau, S. M., Boyle, K. M., Valentine, K., Cloward, T. V., & Shilling, K. C. (2007). Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 3: 455–461. Retrieved from http://​europepmc.​org/​abstract/​MED/​17803007. Walker, J. M., Farney, R. J., Rhondeau, S. M., Boyle, K. M., Valentine, K., Cloward, T. V., & Shilling, K. C. (2007). Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 3: 455–461. Retrieved from http://​europepmc.​org/​abstract/​MED/​17803007.
Metagegevens
Titel
The relationship between sleep and opioids in chronic pain patients
Auteurs
Amy Frers
Jonathan Shaffer
Jack Edinger
Amy Wachholtz
Publicatiedatum
20-02-2021
Uitgeverij
Springer US
Gepubliceerd in
Journal of Behavioral Medicine / Uitgave 3/2021
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI
https://doi.org/10.1007/s10865-021-00205-1

Andere artikelen Uitgave 3/2021

Journal of Behavioral Medicine 3/2021 Naar de uitgave